Impact of Implementing Nasal High Flow Therapy on Body Growth in Preterm Infants.

ABSTRACT:

Introduction

The objective of this study was to determine the impact of nasal high flow (nHF) implementation on lung growth at 6 months corrected age (CA) in preterm infants.

Methods

This single-center retrospective cohort study included preterm infants born <30 weeks' gestation and surviving to 6 months CA at the neonatal intensive care unit of the Amsterdam University Medical Centers. In the nCPAP cohort (2009-2012), continuous distending pressure (CDP) was applied solely with nasal continuous positive airway pressure support. In the nHF cohort (2015-2018), nCPAP was used and followed by nHF therapy to deliver CDP. Bodyweight and length at 6 months CA were used as a proxy for lung growth. We also assessed the impact on respiratory management and neonatal morbidity. Multiva

SUBMITTER: de Ridder R 

PROVIDER: S-EPMC12286588 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature